Patents by Inventor Daniel John Lightwood

Daniel John Lightwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for identifying antibody producing cells
    Patent number: 7993864
    Abstract: The present invention provides a homogeneous assay for identifying an antibody producing cell producing an antibody which binds to a selected antigen comprising: a) providing a population of antibody producing cells; b) incubating said population of antibody producing cells with a selected antigen and a labeled anti-antibody antibody, wherein said anti-antibody antibody is capable of distinguishing cells producing an antibody which binds to the selected antigen from those cells which do not; and c) identifying an antibody producing cell capable of producing an antibody which binds to the selected antigen.
    Type: Grant
    Filed: December 1, 2003
    Date of Patent: August 9, 2011
    Assignee: UCB Pharma S.A.
    Inventors: Derek Thomas Brown, Lisa Butler, Karen Dorothy Cromie, Meryn Ruth Griffiths, Alastair David Griffiths Lawson, Daniel John Lightwood
  • ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13
    Publication number: 20100260773
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: March 10, 2010
    Publication date: October 14, 2010
    Inventors: Neil Gozzard, Alastair David Griffiths Lawson, Daniel John Lightwood, Roger Thomas Palframan, Bryan John Smith, Kerry Louise Tyson
  • Methods for producing antibodies
    Patent number: 7790414
    Abstract: The invention relates to a method of obtaining an antibody with a desired function, the method comprising: a) bringing a population of B cells into contact with a capturing agent; b) separating the captured B cells from the uncaptured B cells; c) culturing a plurality of captured B cells wherein said B cells have not been sorted into single B cells immediately prior to culturing; d) screening a plurality of the cultured cells to identify cells capable of producing an antibody with the desired function; and e) obtaining the desired antibody therefrom.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: September 7, 2010
    Assignee: UCB Pharma S.A.
    Inventors: Alastair David Griffiths Lawson, Daniel John Lightwood